Breast Radiology Reporting - 1st STU ballot
0.2.0 - STU 1 Ballot 2020May
Breast Radiology Reporting - 1st STU ballot
0.2.0 - STU 1 Ballot 2020May
Breast Radiology Reporting - 1st STU ballot - Local Development build (v0.2.0). See the Directory of published versions
Source view
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:ValueSet; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "BiRadsAssessmentCategoriesVS"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>BiRads(r) Assessment Category ValueSet</h2><div><p>BiRads(r) Assessment Category value set.</p>\n</div><ul><li>Include these codes as defined in <a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html\"><code>http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category0\">Category0</a></td><td>Category 0 (Incomplete)</td><td>Need additional Imaging Evaluation and/or prior Mammograms <br/>for comparison. <br/>Recall for additional imaging and/or comparison with <br/>prior examination(s) <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category2\">Category2</a></td><td>Category 2 (Benign)</td><td>This is a normal assessment. <br/>Benign refers to a condition, tumor, or growth that <br/>is not cancerous. <br/>This means that it does not spread to other parts <br/>of the body. <br/>It does not invade nearby tissue. <br/>Essentially 0% likelihood of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category3\">Category3</a></td><td>Category 3 (Probably Benign)</td><td>A finding assessed using this category should have <br/>a <= 2% likelihood of malignancy, <br/>but greater than the essentially 0% likelihood of <br/>malignancy of a characteristically <br/>benign finding. <br/>A probably benign finding is not expected to change <br/>over the suggested period of <br/>imaging surveillance, but the interpreting physician <br/>prefers to establish stability <br/>of the finding before recommending management limited <br/>to routine mammography screening. <br/>Six month follow-up and/or <br/>surveillance mammography is recommended. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4\">Category4</a></td><td>Category 4 (Suspicious)</td><td>This category is reserved for findings that do not <br/>have the classic appearance of <br/>malignancy but are sufficiently suspicious to justify <br/>a recommendation for biopsy. <br/>There is a 2% likelihood of malignancy (cancer). <br/>Almost all recommendations for breast interventional <br/>procedures will come from assessments <br/>made using <br/>this category. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4A\">Category4A</a></td><td>Category 4A (Low suspicion)</td><td>Low suspicion for malignancy. <br/>A malignant finding is not suspected. <br/>A biopsy or other test will likely still be performed <br/>in order to determine. <br/>Tissue diagnosis may be recommended. <br/>Six month follow-up and/or surveillance mammography <br/>is recommended. <br/>Likelihood of malignancy is > 2% to <= 10% likelihood <br/>of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4B\">Category4B</a></td><td>Category 4B (Moderate suspicion)</td><td>Category 4B: Moderate suspicion for malignancy. <br/>It warrants radiologic and pathologic correlation <br/>after tissue diagnosis. <br/>Likelihood of malignancy is > 10% to <= 50% likelihood <br/>of <br/>malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4C\">Category4C</a></td><td>Category 4C (High suspicion)</td><td>Category 4C: High suspicion for <br/>malignancy. <br/>Includes findings that have a high suspicion of malignancy <br/>but that are not highly <br/>suggestive of malignancy (category 5). <br/>Tissue Diagnosis is highly recommended. <br/>Range for likelihood of malignancy is > 50% to < <br/>95% likelihood of malignancy. <br/>It is more likely malignant versus benign. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category5\">Category5</a></td><td>Category 5 (Highly Suggestive of Malignancy)</td><td>Highly Suggestive of Malignancy. <br/>Almost certainly predictive of breast cancer with <br/>a <br/>value of at least 95%. <br/>Tissue Diagnosis is highly recommended or required. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category6\">Category6</a></td><td>Category 6 (Known Biopsy-Proven Malignancy)</td><td>Known Biopsy-Proven Malignancy. <br/>Surgical excision when clinically <br/>appropriate. <br/>This category is only used for findings on a mammogram <br/>that have already been shown to be cancer by a previous <br/>biopsy. <br/>Mammograms may be used in this way to see how well <br/>the cancer is responding to treatment. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr></table></li></ul></div>" ]; fhir:ValueSet.url [ fhir:value "http://hl7.org/fhir/us/breast-radiology/ValueSet/BiRadsAssessmentCategoriesVS"]; fhir:ValueSet.version [ fhir:value "0.2.0"]; fhir:ValueSet.name [ fhir:value "BiRadsAssessmentCategoriesVS"]; fhir:ValueSet.title [ fhir:value "BiRads(r) Assessment Category ValueSet"]; fhir:ValueSet.status [ fhir:value "draft"]; fhir:ValueSet.date [ fhir:value "2019-11-01T00:00:00+00:00"^^xsd:dateTime]; fhir:ValueSet.publisher [ fhir:value "Hl7 - Clinical Interoperability Council"]; fhir:ValueSet.contact [ fhir:index 0; fhir:ContactDetail.telecom [ fhir:index 0; fhir:ContactPoint.system [ fhir:value "url" ]; fhir:ContactPoint.value [ fhir:value "http://hl7.org/Special/committees/cic" ] ] ]; fhir:ValueSet.description [ fhir:value "BiRads(r) Assessment Category value set."]; fhir:ValueSet.jurisdiction [ fhir:index 0; fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://unstats.un.org/unsd/methods/m49/m49.htm" ]; fhir:Coding.code [ fhir:value "001" ] ] ]; fhir:ValueSet.compose [ fhir:ValueSet.compose.include [ fhir:index 0; fhir:ValueSet.compose.include.system [ fhir:value "http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS" ]; fhir:ValueSet.compose.include.concept [ fhir:index 0; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category0" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 0 (Incomplete)" ] ], [ fhir:index 1; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category2" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 2 (Benign)" ] ], [ fhir:index 2; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category3" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 3 (Probably Benign)" ] ], [ fhir:index 3; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category4" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 4 (Suspicious)" ] ], [ fhir:index 4; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category4A" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 4A (Low suspicion)" ] ], [ fhir:index 5; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category4B" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 4B (Moderate suspicion)" ] ], [ fhir:index 6; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category4C" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 4C (High suspicion)" ] ], [ fhir:index 7; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category5" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 5 (Highly Suggestive of Malignancy)" ] ], [ fhir:index 8; fhir:ValueSet.compose.include.concept.code [ fhir:value "Category6" ]; fhir:ValueSet.compose.include.concept.display [ fhir:value "Category 6 (Known Biopsy-Proven Malignancy)" ] ] ] ]. # - ontology header ------------------------------------------------------------ a owl:Ontology; owl:imports fhir:fhir.ttl.
IG © 2019+ Hl7 - Clinical Interoperability Council. Package hl7.fhir.us.breast-radiology#0.2.0 based on FHIR 4.0.1. Generated 2020-04-07
Links: Table of Contents |
QA Report | Search
| Version History 
|
|
Propose a change